Skip to main content

David Fox

ID:LEX-AR-GW0RFHNF

/

Unclaimed

/

Organization: Hogan Lovells

Pacira settlement could have ripple effects on a range of FDA issues far beyond promotional claims

Focus on Regulation · January 7, 2016

FDA Publishes Draft Guidances and Memorandum of Understanding on Drug Compounding and Repackaging

Focus on Regulation · February 23, 2015

FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision in Novartis AG v. Lee alters patent term adjustment

Focus on Regulation · February 27, 2014

FDA Calls for Nominations of Difficult to Compound Drugs

Focus on Regulation · December 16, 2013

The First Drug with a Breakthrough Therapy Designation Receives FDA Approval

Focus on Regulation · November 5, 2013